DAITO PHARMACEUTICAL CO.LTD revenue for the last year amounted to 45.10 B JPY, the most of which — 26.10 B JPY — came from its highest performing source at the moment, Formulation, the year earlier bringing 23.70 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought DAITO PHARMACEUTICAL CO.LTD 45.10 B JPY, and the year before that — 43.46 B JPY.